Pharma turns to big data to gauge care and pricing
Big pharma companies are turning to big data in an attempt to keep up with shifts in market demand. Swiss-based Novartis is no different.
After many years building successful technology businesses, Jeremy Sohn never imagined that at 43 he would find himself on the payroll of...…